Asthma: all 4,012 studies

Page 6 of 41. Open to participants first (515), then studies with results posted, then the rest; newest registration first within each.

• Pediatric Arm of DZL All Age Asthma CohortRecruitingNCT02496468
• Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.RecruitingNCT02455687Phase 3
• Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)RecruitingNCT02419274
• Structure and Function MRI of AsthmaRecruitingNCT02351141Not applicable
• NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)RecruitingNCT02327897
• Spirometric Response to Bronchial Thermoplasty in Patients With Severe AsthmaRecruitingNCT02241265
• Identification of Asthma Phenotypes in Severe AsthmaticsRecruitingNCT01623089
• Asthma Inflammation ResearchEnrolling by invitationNCT01536522Early Phase 1
• Mechanism(s) of Airflow Limitation During Exacerbation of AsthmaRecruitingNCT01225913Phase 4
• Study of the Effect of Innate on the Inflammatory Response to EndotoxinRecruitingNCT01143480
• Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway InflammationRecruitingNCT00595491Phase 1
• Mechanism(s)of Airflow Limitation in Moderate-severe Persistent AsthmaRecruitingNCT00576069
• Personalized Environment and Genes StudyRecruitingNCT00341237
• Role of Genetic Factors in the Development of Lung DiseaseRecruitingNCT00001532
• Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruitingNCT00001406
• Risk Factors, Costs, and Impacts of ED BoardingCompletedNCT07532564Results posted
• Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma CohortsCompletedNCT06922760Results posted
• Non-Interventional Study to Describe the Clinical Management in Asthmatic Patients (NICMA)CompletedNCT06811155Results posted
• A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild AsthmaCompletedNCT06702462Phase 1Results posted
• A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With AsthmaCompletedNCT06644924Phase 2Results posted
• Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy ParticipantsCompletedNCT06506266Phase 1Results posted
• A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 InclusiveCompletedNCT06433908Phase 1Results posted
• Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled AsthmaActive, not recruitingNCT06372496Phase 4Results posted
• Individualizing Treatment for Asthma in Primary CareCompletedNCT06272370Phase 4Results posted
• A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With AsthmaCompletedNCT06261957Phase 3Results posted
• A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With AsthmaCompletedNCT06245551Phase 3Results posted
• Effectiveness of Anti-IL-5/IL5R InhibitorsCompletedNCT06239441Results posted
• Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high AsthmaTerminatedNCT05935332Phase 2Results posted
• Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled AsthmaCompletedNCT05850494Phase 3Results posted
• BREATHE-Peds Pilot- II III Trial and Post TrialCompletedNCT05832437Not applicableResults posted
• Usability and Acceptability Study of the P-STEP Mobile ApplicationCompletedNCT05830318Results posted
• Enhanced Community-Based Asthma Monitoring Through Novel TechnologyCompletedNCT05824936Not applicableResults posted
• A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)CompletedNCT05755906Phase 3Results posted
• Evaluate Pharmacokinetics and Safety of Slow Release DHEACompletedNCT05623059Phase 1/2Results posted
• Pictograms to Facilitate Comprehension of Medical IndicationsTerminatedNCT05609760Not applicableResults posted
• A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult ParticipantsCompletedNCT05602025Phase 1Results posted
• PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway ObstructionCompletedNCT05555290Phase 3Results posted
• BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory ImagingCompletedNCT05552508Phase 4Results posted
• A Comparison of PT027 vs PT007 Used as Needed in Participants With AsthmaCompletedNCT05505734Phase 3Results posted
• Exacerbation Risk in AsthmaCompletedNCT05501639Results posted
• A Study to Compare the Effects of Two Propellants in Adults With Mild AsthmaCompletedNCT05472662Phase 2Results posted
• Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs FluticasoneCompletedNCT05457855Results posted
• Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in AsthmaticsCompletedNCT05448651Phase 1Results posted
• CARE FOR ALL：an Evaluation of an Asthma QIPCompletedNCT05440097Phase 4Results posted
• Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe AsthmaCompletedNCT05421598Phase 2Results posted
• Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaTerminatedNCT05398263Phase 3Results posted
• FAsenra Safety Trial in IndiaCompletedNCT05384938Phase 4Results posted
• Administration of ARS-1 or Albuterol in Subjects With Persistent AsthmaCompletedNCT05363670Phase 2Results posted
• Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United StatesCompletedNCT05329194Phase 4Results posted
• Financial Incentives to Improve AsthmaCompletedNCT05322044Not applicableResults posted
• Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung DiseaseTerminatedNCT05292950Phase 1/2Results posted
• A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidCompletedNCT05292586Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.CompletedNCT05288504Phase 2Results posted
• E-cigarettes for Harm Reduction in Adults With AsthmaCompletedNCT05278065Not applicableResults posted
• Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe AsthmaCompletedNCT05274815Phase 3Results posted
• An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)CompletedNCT05243680Phase 3Results posted
• Home Air Quality Impact for Adults With AsthmaCompletedNCT05224076Results posted
• A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)CompletedNCT05202262Phase 3Results posted
• Timely Intravenous Magnesium for Asthma in ChildrenCompletedNCT05166811Phase 2Results posted
• Impulse Oscillometry Measurements in Severe Eosinophilic Asthmatics Before and After Anti-IL-5 Factor InitiationCompletedNCT05147155Results posted
• Study of GSK3511294 in Healthy Chinese ParticipantsCompletedNCT05140200Phase 1Results posted
• Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)CompletedNCT05087693Phase 4Results posted
• Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With AsthmaCompletedNCT05062759Phase 3Results posted
• Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe AsthmaCompletedNCT05036733Phase 4Results posted
• Breathing Retraining for Asthma Trial of Home Exercises for TeenagersCompletedNCT05006703Not applicableResults posted
• EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 PatientsCompletedNCT04998604Phase 4Results posted
• Teva Asthma Predictive Analytics StudyCompletedNCT04997304Phase 4Results posted
• Safety and Efficacy Active Drug vs. Placebo in Subjects With AsthmaTerminatedNCT04987944Phase 1Results posted
• Adapting Body Reprogramming for Severe Asthma: a Feasibility StudyCompletedNCT04980755Not applicableResults posted
• Asthma Link: A Real World Application of School Supervised Asthma TherapyCompletedNCT04942379Not applicableResults posted
• Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled AsthmaCompletedNCT04937387Phase 3Results posted
• Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild AsthmaticsCompletedNCT04933383Phase 1/2Results posted
• Improving Asthma Care Together (IMPACT): A Shared Management Pilot StudyCompletedNCT04908384Not applicableResults posted
• Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma TriggersCompletedNCT04896502Not applicableResults posted
• US PRECISION Implementation StudyCompletedNCT04891978Not applicableResults posted
• Study in Adult Patients With Moderate to Severe AsthmaCompletedNCT04886999Phase 3Results posted
• Managing Asthma Patients With AMAZE™: A Novel Disease Management PlatformCompletedNCT04868500Not applicableResults posted
• To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.CompletedNCT04848662Phase 1Results posted
• A Study to Test if TEV-53275 is Effective in Relieving AsthmaTerminatedNCT04847674Phase 2Results posted
• A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With AsthmaCompletedNCT04813354Phase 4Results posted
• Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways DiseasesCompletedNCT04765722Phase 4Results posted
• Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in AdolescentsCompletedNCT04748055Results posted
• A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)CompletedNCT04728711Phase 2Results posted
• Promoting Risk Reduction Among Young Adults With Asthma During Wildfire Smoke Events (TRAK)CompletedNCT04724733Not applicableResults posted
• Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic PhenotypeCompletedNCT04719832Phase 3Results posted
• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic PhenotypeCompletedNCT04718389Phase 3Results posted
• A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic PhenotypeCompletedNCT04718103Phase 3Results posted
• A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With AsthmaCompletedNCT04677959Phase 4Results posted
• Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With AsthmaCompletedNCT04673630Phase 1Results posted
• Identification of Autoantigens in EGPA and Severe Eosinophilic AsthmaCompletedNCT04671446Results posted
• AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency DepartmentTerminatedNCT04669288Phase 3Results posted
• Evaluation of Triple Therapy Using Magnetic Resonance Imaging in AsthmaActive, not recruitingNCT04651777Phase 3Results posted
• Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled CorticosteroidsTerminatedNCT04643158Phase 2Results posted
• Defining and Treating Depression-related AsthmaCompletedNCT04617015Early Phase 1Results posted
• Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19CompletedNCT04613739Not applicableResults posted
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)CompletedNCT04609904Phase 3Results posted
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)CompletedNCT04609878Phase 3Results posted
• Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With AsthmaCompletedNCT04589663Phase 2Results posted
• Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable AsthmaticsCompletedNCT04585009Phase 1Results posted
• Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe AsthmaCompletedNCT04570657Phase 2Results posted

← Asthma overview